Circular RNA Profile in Atherosclerotic Disease: Regulation during ST-Elevated Myocardial Infarction.

In contrast, the modest increase in the placebo group did not reach statistical significance (FGE 1.0 vs. 1.26; p = 0.18) ( Figure 5 ). circUBAC2 levels increased from admission to 3–7 days in the placebo arm (FGE 1.0 vs. 1.48; p < 0.05) as well as in the tocilizumab arm (1.0 vs. 1.91; p < 0.001).

also in 111,027 other papers